Erfonrilimab is a investigational drug being evaluated for use in cancer immunotherapy. It is a bispecific antibody targeting PD-L1 and CTLA-4.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.